Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Cash Flow (2022 - 2025)

Praxis Precision Medicines has reported Net Cash Flow over the past 4 years, most recently at $207.8 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $207.8 million for Q4 2025, up 344.72% from a year ago — trailing twelve months through Dec 2025 was $142.0 million (up 5.88% YoY), and the annual figure for FY2025 was $142.0 million, up 5.88%.
  • Net Cash Flow for Q4 2025 was $207.8 million at Praxis Precision Medicines, up from -$7.9 million in the prior quarter.
  • Over the last five years, Net Cash Flow for PRAX hit a ceiling of $207.8 million in Q4 2025 and a floor of -$61.4 million in Q1 2022.
  • Median Net Cash Flow over the past 4 years was -$3.8 million (2022), compared with a mean of $13.6 million.
  • Biggest five-year swings in Net Cash Flow: plummeted 2298.18% in 2023 and later skyrocketed 344.72% in 2025.
  • Praxis Precision Medicines' Net Cash Flow stood at -$825000.0 in 2022, then plummeted by 2298.18% to -$19.8 million in 2023, then soared by 336.17% to $46.7 million in 2024, then skyrocketed by 344.72% to $207.8 million in 2025.
  • The last three reported values for Net Cash Flow were $207.8 million (Q4 2025), -$7.9 million (Q3 2025), and -$8.2 million (Q2 2025) per Business Quant data.